发明名称 A mouse model for hepatocellular carcinoma by targeted integration of hepatitis B virus genes
摘要 The invention provides a mouse model of hepatocellular carcinoma and a method for establishing an animal model comprising: a) inserting an exogenous gene of interest into a suitable vector carrying sequences homologous to a target site, to construct a recombinant targeting vector; b) transfecting ES cells of a studied animal using said targeting vector from step a), and screening targeted ES cells which have integrated the exogenous gene into a specific site; c) injecting targeted ES cells obtained from step b) into said animal's blastulas and culturing the blastulas in vitro, so that embryos containing targeted ES cells are generated; and d) implanting embryos generated from step c) into said animal's uterus, thereby progeny expressing the exogenous gene stably is developed. <??>The invention further relates to the use of said transgenic mouse in research of hepatocellular carcinoma pathogenesis, its early stage diagnosis and therapy, and screening of anticancer drugs. <IMAGE>The invention provides a mouse model of hepatocellular carcinoma and a method for establishing an animal model comprising: a) inserting an exogenous gene of interest into a suitable vector carrying sequences homologous to a target site, to construct a recombinant targeting vector; b) transfecting ES cells of a studied animal using said targeting vector from step a), and screening targeted ES cells which have integrated the exogenous gene into a specific site; c) injecting targeted ES cells obtained from step b) into said animal's blastulas and culturing the blastulas in vitro, so that embryos containing targeted ES cells are generated; and d) implanting embryos generated from step c) into said animal's uterus, thereby progeny expressing the exogenous gene stably is developed. <??>The invention further relates to the use of said transgenic mouse in research of hepatocellular carcinoma pathogenesis, its early stage diagnosis and therapy, and screening of anticancer drugs. <IMAGE>
申请公布号 EP1362510(A2) 申请公布日期 2003.11.19
申请号 EP20030010880 申请日期 2003.05.15
申请人 BEIJING INSTITUTE OF BIOTECHNOLOGY 发明人 YANG, XIAO;WANG, YOULIANG;LU, YAXIN;HUANG, CUIFEN;CUI, FANG
分类号 A01K67/027;C07K14/02;C12N5/10;C12N15/09;C12N15/85;(IPC1-7):A01K67/027 主分类号 A01K67/027
代理机构 代理人
主权项
地址